Produktinformation
- 3-[(6-Deoxy-2-O-β-D-xylopyranosyl-α-L-mannopyranosyl)oxy]-7-(β-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-bute n-1-yl)-4H-1-benzopyran-4-one
- 3-((6-Deoxy-2-O-beta-D-xylopyranosyl-alpha-L-mannopyranosyl)oxy)-7-(beta-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one
- 3-[(6-Deoxy-2-O-β-<span class="text-smallcaps">D</smallcap>-xylopyranosyl-α-<smallcap>L</smallcap>-mannopyranosyl)oxy]-7-(β-<smallcap>D</span>-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one
- 3-[(6-deoxy-2-O-beta-D-xylopyranosyl-alpha-L-mannopyranosyl)oxy]-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside
- 4H-1-Benzopyran-4-one, 3-[(6-deoxy-2-O-β-<span class="text-smallcaps">D</smallcap>-xylopyranosyl-α-<smallcap>L</smallcap>-mannopyranosyl)oxy]-7-(β-<smallcap>D</span>-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-
- 4H-1-Benzopyran-4-one, 3-[(6-deoxy-2-O-β-<span class="text-smallcaps">D</smallcap>-xylopyranosyl-α-<smallcap>L</smallcap>-mannopyranosyl)oxy]-7-(β-<smallcap>D</span>-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-
- 4H-1-Benzopyran-4-one,3-[(6-deoxy-2-O-β-D-xylopyranosyl-α-L-mannopyranosyl)oxy]-7-(β-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-
- Epimedin B(Primary Standard)
- 4H-1-Benzopyran-4-one, 3-[(6-deoxy-2-O-β-D-xylopyranosyl-α-L-mannopyranosyl)oxy]-7-(β-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-
- 3-[(6-Deoxy-2-O-β-D-xylopyranosyl-α-L-mannopyranosyl)oxy]-7-(β-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one
- Mehr Synonyme anzeigen
Epimedin B is a natural product that has been shown to have antitumor activity. Epimedin B contains a variety of chemical structures that are thought to act on the cell surface and inhibit receptor binding, leading to the inhibition of tumor growth and progression. Epimedin B has been shown to bind to the response element in cervical cancer cells, which leads to an increased expression of transforming growth factor beta-1 (TGF-β1). Epimedin B also exhibits molecular docking with flavonoid glycosides, which may account for its antioxidant properties. The most active component in Epimedin B is phenolic acid. This compound is thought to be responsible for the anti-inflammatory and immunosuppressive activities observed in animal studies. In addition, phenolic acid is a potent inhibitor of nitric oxide synthase (NOS), an enzyme associated with tumor promotion.
Chemische Eigenschaften
Technische Anfrage zu: 3D-OE08121 Epimedin B
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.